Source: International Congress 2015 – Pulmonary hypertension: promising small molecules
Disease area: Airway diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Priscilla Henno (Paris, France), Priscilla Henno, Christelle Maurey, Françoise Le Pimpec-Barthes, Philippe Devillier, Christophe Delclaux, Dominique Israël-Biet. Is arginase a potential drug target in tobacco-induced pulmonary endothelial dysfunction?. Eur Respir J 2015; 46: Suppl. 59, 4904

Member's Comments

No comment yet.

Related content which might interest you: The cycle of the nitric oxide metabolism in patients with COPD and chronic cerebrovascular diseases (CCVD) Source: Annual Congress 2013 –The vulnerable patient and ageing cells Year: 2013 iNOS affects matrix production in distal lung fibroblasts from patients with mild asthma Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 Gene polymorphisms of endothelial nitric oxide synthase in pulmonary arterial hypertension Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology Year: 2005 Reduce expression of endothelial nitric oxide synthase lead to more severe pulmonary complex vascular lesions associated with HIV Source: International Congress 2018 – Experimental research in pulmonary hypertension Year: 2018 iNOS expression is increased in peripheral airways of asthmatic patients Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases Year: 2015 Fractional exhaled nitric oxide in chronic obstructive pulmonary disease Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Measurement of exhaled nitric oxide in patients with pulmonary tuberculosis Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Bronchial and alveolar nitric oxide levels in healthy volunteers and patients with severe asthma Source: International Congress 2016 – Airway biomarkers Year: 2016 Nitric oxide modulates vascular remodelling in a model of chronic allergic lung inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 432s Year: 2006 Role of nitric oxide pathway in pathogenesis of high altitude pulmonary hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 551s Year: 2007 Smoking is associated with an age-related decline in exhaled nitric oxide Source: Eur Respir J 2007; 30: 1074-1081 Year: 2007 Nitric oxide from alveolar origin in cirrhotic patients: relationship with pulmonary haemodynamics and potential implications Source: Annual Congress 2008 - Pulmonary hypertension II Year: 2008 Nitric oxide in the COPD pathogenesis in patients with pulmonary tuberculosis Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease Year: 2019 Exhaled nitric oxide levels in patients with pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide Source: Eur Respir J 2007; 30: 26-30 Year: 2007 Cytokine status and nitrosative stress indicators in patients with an exacerbation of COPD Source: International Congress 2015 – Translational research in respiratory care: new findings Year: 2015 Decreased haem oxygenase-1 and increased inducible nitric oxide synthase in the lung of severe COPD patients Source: Eur Respir J 2003; 21: 971-976 Year: 2003 The role of nitric oxide (NO) on sepsis-induced pulmonary apoptosis Source: Eur Respir J 2001; 18: Suppl. 33, 358s Year: 2001 Small airway dysfunction and its role in pediatric asthma control assessment Source: International Congress 2016 – Techniques and tools in paediatric asthma Year: 2016 Elevated levels of alveolar nitric oxide in patients with inflammatory bowel disease Source: International Congress 2016 – Airway biomarkers Year: 2016